28bio
28bio provides human-relevant brain models to improve neurological drug discovery. It uses the Nexon platform to combine tissue engineering, neural interfacing, and AI. The core tech builds engineered brain organoids and scalable systems to study memory and cognitive functions. Target customers are biotechnology and pharmaceutical companies seeking more predictive human models and better therapy selection. The approach aims to scale brain-compatible research and broaden access to human neuroscience data.
28bio
28bio provides human-relevant brain models to improve neurological drug discovery. It uses the Nexon platform to combine tissue engineering, neural interfacing, and AI. The core tech builds engineered brain organoids and scalable systems to study memory and cognitive functions. Target customers are biotechnology and pharmaceutical companies seeking more predictive human models and better therapy selection. The approach aims to scale brain-compatible research and broaden access to human neuroscience data.